<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01244048</url>
  </required_header>
  <id_info>
    <org_study_id>LSEP H35_08</org_study_id>
    <nct_id>NCT01244048</nct_id>
  </id_info>
  <brief_title>Intervention With n3 LC-PUFA-supplemented Yogurt</brief_title>
  <official_title>Intervention With n3 LC-PUFA-supplemented Yogurt: Effects on Cardiovascular Risk Factors and Inflammatory Biomarkers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Jena</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Jena</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effective dosage of a n3-LC-PUFA intervention (with n3 LC-PUFA-enriched yoghurt) on the
      modulation of cardiovascular risk factors and inflammatory biomarkers were determined.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fifty three mildly hypertriacylglycerolemic subjects (TAG ≥ 150 mg/dL (1.7 mmol/L))
      participated on the placebo-controlled, double-blind, parallel designed study.

      The subjects consumed placebo yoghurt (1), or n3 LC-PUFA-enriched yoghurt (0.8 g n3 LC-PUFA/d
      (2), 3 g n3 LC-PUFA/d (3)) for 10 weeks.

      Blood samples were taken at the beginning and at the end of the period.

      Parameters:

        -  Blood lipids (total cholesterol, HDL, LDL, triacylglycerols)

        -  Fatty acid distribution of plasma lipids (PL) and erythrocyte membranes (EM)

        -  Concentrations of eicosanoids (PGs, HETEs)

        -  Production of ex vivo stimulated cytokines by T cells

        -  SNPs in the CD36 genotype
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood lipids (total cholesterol, HDL, LDL, triacylglycerols)</measure>
    <time_frame>change from baseline after 10 weeks</time_frame>
    <description>change from baseline after 10 weeks
Group 1: placebo Group 2: 0.8 g n3 LC-PUFA/125 g yoghurt per day Group 3: 3 g n3 LC-PUFA/200 g yoghurt per day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>fatty acid distribution in plasma lipids and erythrocyte membranes, eicosanoids in plasma, production of ex vivo stimulated cytokines by T cells, SNPs on CD36 genotype</measure>
    <time_frame>change from baseline after 10 weeks</time_frame>
    <description>change from baseline after 10 weeks
Group 1: placebo Group 2: 0.8 g n3 LC-PUFA/125 g yoghurt per day Group 3: 3 g n3 LC-PUFA/200 g yoghurt per day</description>
  </secondary_outcome>
  <enrollment type="Actual">53</enrollment>
  <condition>Moderate Hypertriacylglycerolemic Subjects</condition>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>n3 long chain polyunsaturated fatty acids</intervention_name>
    <description>Group 1 (placebo) Group 2 (0.8 g n3 LC-PUFA/d in 125 g yoghurt) Group 3 (3 g n3 LC-PUFA/d in 200 g yoghurt)</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hypertriacylglycerolemic subjects (TAG: ≥ 150 mg/dl (1.7 mmol/l))

        Exclusion Criteria:

          -  patients receiving blood-diluting and lipid-lowering medications or glucocorticoids

          -  patients suffering from gastrointestinal or metabolic diseases (e.g., diabetes
             mellitus, hyper- and hypothyroidism) and hypercholesteremic patients with familial
             previous impacts

          -  patients taking dietary supplements (e.g., fish oil capsules, vitamin E) or having
             either known allergies or foodstuff indigestibility

          -  further exclusion criteria: smoking, high sportive activity or daily alcohol intake
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerhard Jahreis, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Nutrition, University Jena</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Jena, Institute of Nutrition, Department of Nutritional Physiology</name>
      <address>
        <city>Jena</city>
        <zip>07743</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2010</study_first_submitted>
  <study_first_submitted_qc>November 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2010</study_first_posted>
  <last_update_submitted>March 6, 2012</last_update_submitted>
  <last_update_submitted_qc>March 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Jena</investigator_affiliation>
    <investigator_full_name>Gerhard Jahreis</investigator_full_name>
    <investigator_title>Proffessor Dr. G. Jahreis</investigator_title>
  </responsible_party>
  <keyword>n3 LC-PUFA, yoghurt, inflammatory markers</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

